Sensitive Molecular Diagnostics for Cutaneous Leishmaniasis

Orli Sagi1, Anat Berkowitz1,2, Shlomi Codish3

  • 1Clinical Parasitology.

Insights

A new multiplex qPCR test accurately diagnoses cutaneous leishmaniasis (CL) and identifies Leishmania species from lesion swabs. This rapid diagnostic tool aids in managing CL caused by Old World and New World Leishmania strains.

Area of Science:

  • Medical Parasitology
  • Molecular Diagnostics
  • Infectious Diseases

Background:

  • Cutaneous leishmaniasis (CL) diagnosis and species identification are crucial for effective disease management.
  • In Israel, CL is primarily caused by Leishmania major and Leishmania tropica.
  • Accurate and rapid diagnostic methods are needed for timely treatment.

Purpose of the Study:

  • To develop and validate a point-of-care diagnostic test for Leishmania species.
  • To enable rapid and accurate identification of Leishmania parasites in clinical samples.
  • To differentiate between Old World and New World Leishmania species.

Main Methods:

  • Establishment of a lesion-swabbing technique for sample collection.
  • Development of a sensitive multiplex real-time PCR (qPCR) assay.
  • Utilized three probes for general Leishmania, L. major, and L. tropica detection.

Main Results:

  • Screened 1783 clinical samples over two years.
  • Detected Leishmania species in 1086 individuals (1008 L. major, 70 L. tropica).
  • Identified L. braziliensis and L. infantum/donovani in 8 samples using a secondary multiplex qPCR.

Conclusions:

  • The multiplex qPCR test provides accurate diagnostics for Leishmania infections.
  • Enabled subtyping of dominant Leishmania strains in the region.
  • Facilitated better treatment strategies for CL patients, including travelers.
Abstract

Related Concept Videos

Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...